Right ventricular myocardial infarction
 |
Resident Survival Guide |
|
Right ventricular myocardial infarction Microchapters |
|
Differentiating Right ventricular myocardial infarction from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Pharmacological Reperfusion |
|
Mechanical Reperfusion |
|
Antithrombin Therapy |
|
Antiplatelet Agents |
|
Other Initial Therapy |
|
Right ventricular myocardial infarction On the Web |
|
Directions to Hospitals Treating Right ventricular myocardial infarction |
|
Risk calculators and risk factors for Right ventricular myocardial infarction |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Priyamvada Singh, M.D. [3]
Overview
Pathophysiology
Pathophysiology of Reperfusion | Gross Pathology | Histopathology
Causes
Differentiating Right ventricular myocardial infarction from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Electrocardiogram | Chest X Ray | Echocardiography or Ultrasound | Coronary Angiography | Other Imaging Findings
Treatment
Initial Care
Pharmacologic Reperfusion: Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI) | Fibrinolysis
Mechanical Reperfusion: The Importance of Reducing Door-to-Balloon Times | Primary PCI | Adjunctive and Rescue PCI | Rescue PCI | Facilitated PCI | Adjunctive PCI | CABG | Management of Patients Who Were Not Reperfused | Assessing Success of Reperfusion
Antithrombin Therapy: Antithrombin Therapy | Unfractionated Heparin | Low Molecular Weight Heparinoid Therapy | Direct Thrombin Inhibitor Therapy | Factor Xa Inhibition | DVT Prophylaxis | Long Term Anticoagulation
Antiplatelet Agents: Aspirin | Thienopyridine Therapy | Glycoprotein IIbIIIa Inhibition
Other Initial Therapy: Inhibition of the Renin-Angiotensin-Aldosterone System | Magnesium Therapy | Glucose Control | Calcium Channel Blocker Therapy